Investor profile for Fountain Healthcare Partners: stage-based planning range, investment stages, sector focus, portfolio companies, sources, and verification status. Part of the Venture Capital Tracker directory.

VC fund profile · evidence-aware directory data

Fountain Healthcare Partners stages, portfolio and investment profile

Fountain Healthcare Partners is a life-sciences venture capital firm. It participated in Altay Therapeutics' $37 million Series A announced closed on October 14, 2026. Its investment was part of a syndicate co-led by Sound Bioventures and HealthCap; the individual check and valuation were not disclosed.

Keep track of Fountain Healthcare Partners

Save this profile to your VCT watchlist for a quick return.

View watchlist

Stage-based planning range

$1M–$10M

This is a planning range inferred from stage coverage, not a firm-disclosed check size.

Methodology: Stage bucket inferred from the rounds a fund leads or invests in.

No firm-specific check-size disclosure is recorded.

Source link not recorded Confidence: 25% Verified: October 15, 2026 View methodology

Investment stages

Leads: Not recorded

Participates: Series A

Sector focus

biotech-life-sciences

Geography

Not recorded

Founded Not recorded

Fund size / AUM

Not recorded

A separate fund-size evidence record is not yet available.

Portfolio in our directory

1

Linked startup profiles

Latest fund vehicle

Not recorded

Vehicle name, size, and vintage are not yet structured.

Recent tracked investment

Not recorded

No dated round explicitly links this fund.

Rounds they lead

Rounds they invest

Series A

Last verified: 2026-10-15T07:20:00Z. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.

Portfolio companies we track

Startups in our directory that list Fountain Healthcare Partners as an investor (1 total).

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.